KZR-616 Uses, Dosage, Side Effects and more
KZR-616 is under investigation in clinical trial NCT04033926 (A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis).
| Trade Name | KZR-616 |
| Generic | KZR-616 |
| Type | |
| Formula | C30H42N4O8 |
| Weight | Average: 586.686 Monoisotopic: 586.300264328 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
